Vinge has advised the sellers in connection with the sale of Advectas to Capgemini. Advectas conducts operations within, among other things, business intelligence.
Vinge has advised in connection with the sale of Kynningsrud Prefab Holding, which is a manufacturer of concrete elements for the construction industry.
Vinge has advised Swegon in connection with the acquisition of Waterloo Group Limited, which is a leading manufacturer air terminal devices in the United Kingdom.
Vinge has advised Fidelio Capital on the acquisition of BioMedtrix, LLC. BioMedtrix is a leading company within the market for veterinary orthopedic implants and instruments.
Vinge has advised Litorina and other shareholders in connection with the sale of Fiskarhedenvillan to the company’s CEO and a group of industrial partners.
Vinge has advised Santander Consumer Bank AS in connection with its acquisition of all shares in Forso Nordic AB, a subsidiary within the Ford Motor Company group.
Vinge has advised Asept International AB, a subsidiary of Lagercrantz Group AB, in connection with the acquisition of all shares in the UNRO Dispenser System AB and SDP Scandinavian Dispenser Products AB.
Vinge has advised the pharmaceutical development company Cinclus Pharma in connection with a capital raising of approximately SEK 250 million by way of a directed share issue to several new investors and current shareholders.
Vinge has advised Industrifonden in connection with Industrifonden’s investment in ShardSecure Inc. ShardSecure has developed Microshard™ which increases the security of data in cloud solutions.
Vinge has advised Industrifonden in connection with Industrifonden leading a financing round in the amount of EUR 6 million in Elypta, a Swedish company which works with cancer diagnostics.
Vinge has advised Equitix in conjunction with the acquisition of all shares in Brotorp Power AB, which owns and operates the 46.2 MW Brotorp wind park in Mönsterås Municipality, from BlackRock.
Vinge has advised Bygghemma Sverige AB in connection with the acquisition of 84 per cent of the shares in Hemfint Kristianstad AB for a fixed purchase price regarding 51 per cent of the shares, an earn-out based purchase price regarding 33 per cent of the shares over a 3-year period as well as an option to acquire the remaining shares within 3-4 years.
